The Smoking MUMS (Maternal Use of Medications and Safety) Study

Funded by NHMRC Project Grant.

Little is known about the utilisation, effectiveness and safety of pharmacotherapies for smoking cessation during pregnancy. The Smoking MUMS (Maternal Use of Medications and Safety) Study will explore these issues using routinely collected perinatal data from NSW and WA linked to pharmaceutical data and records of other health service use. In addition to investigating the maternal and neonatal safety of nicotine replacement therapy, bupropion and varenicline use during pregnancy, the Smoking MUMS Study is exploring inequalities in the use of these medications in disadvantaged populations, including Aboriginal women, and whether their use has changed in response to pharmaceutical policy reforms and changes in clinical guidelines.